Lyell Immunopharma, Inc. (LYEL)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 13, 2025 | CORRESP | Neutral/Informational | Moderate | Lyell Immunopharma, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective by August 15, 2… | Read Filing EDGAR |
| Aug. 13, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated August 13, 2025, informs Lynn Seely, CEO of Lyell Immunopharma, Inc., that the SEC has not reviewed and will not review the company's registration sta… | Read Filing EDGAR |
| Jul. 28, 2025 | CORRESP | Neutral/Informational | Moderate | Lyell Immunopharma, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3. The company is seeking to have the regist… | Read Filing EDGAR |
| Jul. 23, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Lyell Immunopharma, Inc. that it will not review their registration statement filed on July 18, 2025. The letter emphasizes the company's responsibilit… | Read Filing EDGAR |